Imperial College London Featured PhD Programmes
The Francis Crick Institute Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
Max Planck Society Featured PhD Programmes
Australia ×
10 miles

Cancer / Oncology PhD Projects, Programs & Scholarships in Australia

We have 33 Cancer / Oncology PhD Projects, Programs & Scholarships in Australia

  • Cancer / Oncology×
  • Australia×
  • clear all
Order by 
Showing 1 to 10 of 33
  Modular design and assembly of innovative biopolymer beads as drug delivery platform
  Prof Bernd Rehm, Dr D Wibowo
Applications accepted all year round

Funding Type

PhD Type

The FDA-approved polyhydroxybutyrate self-assembles in engineered bacteria and forms spherical beads of approximately 200 nm in diameter.
  The role of oesophageal submucosal glands in epithelial homeostasis and the development of Barrett’s oesophagus
  Research Group: Cancer Biology & Surgical Oncology Laboratory
  Prof W. Phillips, Dr N. Clemons
Applications accepted all year round

Funding Type

PhD Type

Barrett’s oesophagus, the premalignant precursor of oesophageal adenocarcinoma, is a metaplastic condition where the normal stratified squamous epithelium that lines the oesophagus is replaced by an intestinal-like columnar epithelium.
  Genomic determinants of long-term survival in ovarian cancer
  Research Group: Cancer Genetics & Genomics Laboratory
  Prof D. Bowtell, Dr D Garsed
Applications accepted all year round

Funding Type

PhD Type

High-grade serous ovarian cancer is an aggressive disease in which only ~30% of women survive 5 years or more. Despite a poor prognosis, a subset of patients are highly responsive to chemotherapy, and some become long-term survivors (>10 years survival).
  A multiple modality approach for targeting treatment-resistant ovarian cancer
  Dr E. Sanij, Prof R. Pearson
Applications accepted all year round

Funding Type

PhD Type

High-grade serous ovarian cancer (HGSOC) accounts for 70% of ovarian cancer (OvCa) deaths and its five-year survival rate is 43%.
  Analytic methods for detecting and making sense of somatic genomic rearrangements
  Prof A Papenfuss
Applications accepted all year round

Funding Type

PhD Type

Bioinformatics is the application of mathematics, statistics and computational methods to the analysis of molecular biology data.
  Cellular cross-talk at the perivascular niche and the blood brain barrier
  Prof B Hogan
Applications accepted all year round

Funding Type

PhD Type

Much research on vasculature has focussed on the endothelial cells that line functional vessels, however the milieu of cells that surround vessels (mural cells) play important and under-appreciated roles in homeostasis and disease.
  Clinical cancer bioinformatics: developing new bioinformatics methods for improved analysis of cancer gene hybridisation capture panels
  Prof A Papenfuss
Applications accepted all year round

Funding Type

PhD Type

Bioinformatics is the application of mathematics, statistics and computational methods to the analysis of molecular biology data.
  Computational simulation of tumour formation and progression
  Dr D. Goode
Applications accepted all year round

Funding Type

PhD Type

Tumours comprise a complex mix of related but distinct cellular subpopulations that both compete and complement one another. These dynamics strongly influence how and when a tumour forms as well as its response to therapy, however there are hard to observe directly.
  Fishing for metabolic clues: Role of the Hippo/Yap pathway in reprogramming metabolism in liver cancer
  Dr A. Cox
Applications accepted all year round

Funding Type

PhD Type

The Hippo/Yap pathway is an evolutionarily conserved cascade that plays a fundamental role in governing organ size control, stem cell homeostasis and cancer.
  Fueling chemotherapy resistance in triple-negative breast cancer
  Dr K Brown
Applications accepted all year round

Funding Type

PhD Type

Triple-negative breast cancer (TNBC) is a molecularly heterogeneous group of diseases defined by the lack of estrogen receptor (ER), progesterone receptor (PR) and absence of human epidermal growth factor receptor-2 (HER2) amplification.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.